Sunday - January 12, 2025
Congressional Research Service Issues In Focus White Paper on "Skinny Labels" for Generic Drugs Under Hatch-Waxman
July 02, 2024
WASHINGTON, July 2 -- The Congressional Research Service issued the following In Focus white paper (No. IF12700) on July 1, 2024, by legislative attorney Kevin J. Hickey:

* * *

"Skinny Labels" for Generic Drugs Under Hatch-Waxman New "brand-name" drugs are often protected from generic competition by patents. In general, a drug manufacturer intending to market a generic version of a brand-name drug must either wait for those patents to expire or chal . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products